
Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning
Oncology Today with Dr Neil Love
00:00
Mose and Tusumab Monotherapy in DLBCL
In large olemboma you know it's a precarious place right now. Getting a CR is usually a window opportunity to do something else in my opinion. I always caution these elderly unfit trials and DLBCL because they're where I know I can't give or at least start or try for all those are chopped.
Transcript
Play full episode